Insider Transactions in Q1 2022 at Pfizer Inc (PFE)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
William Pao Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
115,897
+50.0%
|
-
|
|
Mar 03
2022
|
Mikael Dolsten President R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
102,460
+12.04%
|
$3,381,180
$33.03 P/Share
|
|
Feb 28
2022
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,049
-5.3%
|
$48,254
$46.94 P/Share
|
|
Feb 28
2022
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
740
-3.75%
|
$34,040
$46.94 P/Share
|
|
Feb 28
2022
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,384
-1.84%
|
$63,664
$46.94 P/Share
|
|
Feb 28
2022
|
William R Carapezzi Jr Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,795
-2.46%
|
$82,570
$46.94 P/Share
|
|
Feb 26
2022
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,824
-10.4%
|
$1,025,728
$47.72 P/Share
|
|
Feb 26
2022
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
29,744
-9.18%
|
$1,397,968
$47.72 P/Share
|
|
Feb 26
2022
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
6,402
-12.92%
|
$313,698
$49.18 P/Share
|
|
Feb 26
2022
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
9,713
+27.11%
|
$242,825
$25.6 P/Share
|
|
Feb 26
2022
|
Angela Hwang President, Global Biopharma |
SELL
Payment of exercise price or tax liability
|
Direct |
9,398
-27.56%
|
$460,502
$49.18 P/Share
|
|
Feb 26
2022
|
Angela Hwang President, Global Biopharma |
BUY
Exercise of conversion of derivative security
|
Direct |
12,716
+39.6%
|
$317,900
$25.6 P/Share
|
|
Feb 26
2022
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
21,199
-11.62%
|
$1,038,751
$49.18 P/Share
|
|
Feb 26
2022
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,317
+23.36%
|
$732,925
$25.6 P/Share
|
|
Feb 26
2022
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
8,133
-4.97%
|
$398,517
$49.18 P/Share
|
|
Feb 26
2022
|
Michael Mc Dermott Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
12,340
+12.87%
|
$308,500
$25.6 P/Share
|
|
Feb 26
2022
|
William R Carapezzi Jr Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
14,514
-8.62%
|
$711,186
$49.18 P/Share
|
|
Feb 26
2022
|
William R Carapezzi Jr Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
21,193
+19.52%
|
$529,825
$25.6 P/Share
|
|
Feb 26
2022
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
57,431
-17.89%
|
$2,814,119
$49.18 P/Share
|
|
Feb 26
2022
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
77,709
+30.81%
|
$1,942,725
$25.6 P/Share
|
|
Feb 26
2022
|
Frank A Damelio Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
93,977
-7.49%
|
$4,604,873
$49.18 P/Share
|
|
Feb 26
2022
|
Frank A Damelio Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
127,160
+16.36%
|
$3,179,000
$25.6 P/Share
|
|
Feb 26
2022
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
48,430
-15.05%
|
$2,373,070
$49.18 P/Share
|
|
Feb 26
2022
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
63,580
+26.89%
|
$1,589,500
$25.6 P/Share
|
|
Feb 24
2022
|
Jennifer B. Damico SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,893
+14.99%
|
-
|
|
Feb 23
2022
|
William R Carapezzi Jr Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,744
-10.49%
|
$820,456
$49.07 P/Share
|
|
Feb 23
2022
|
William R Carapezzi Jr Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,632
+23.61%
|
$692,064
$27.34 P/Share
|
|
Feb 23
2022
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,509
-15.16%
|
$1,725,414
$46.87 P/Share
|
|
Feb 23
2022
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
8,154
-20.44%
|
$399,546
$49.07 P/Share
|
|
Feb 23
2022
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
11,748
+35.16%
|
$317,196
$27.34 P/Share
|
|
Feb 23
2022
|
Frank A Damelio Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
114,219
-9.35%
|
$5,596,731
$49.07 P/Share
|
|
Feb 23
2022
|
Frank A Damelio Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
153,789
+19.45%
|
$4,152,303
$27.34 P/Share
|
|
Feb 23
2022
|
Angela Hwang President, Global Biopharma |
SELL
Payment of exercise price or tax liability
|
Direct |
14,682
-40.27%
|
$719,418
$49.07 P/Share
|
|
Feb 23
2022
|
Angela Hwang President, Global Biopharma |
BUY
Exercise of conversion of derivative security
|
Direct |
21,359
+50.0%
|
$576,693
$27.34 P/Share
|
|
Feb 23
2022
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
24,421
-14.16%
|
$1,196,629
$49.07 P/Share
|
|
Feb 23
2022
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
35,457
+27.97%
|
$957,339
$27.34 P/Share
|
|
Feb 23
2022
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
84,861
-26.19%
|
$4,158,189
$49.07 P/Share
|
|
Feb 23
2022
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
115,342
+38.84%
|
$3,114,234
$27.34 P/Share
|
|
Feb 23
2022
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,328
-6.5%
|
$506,072
$49.07 P/Share
|
|
Feb 23
2022
|
Michael Mc Dermott Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
14,952
+15.5%
|
$403,704
$27.34 P/Share
|
|
Feb 23
2022
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,589
-17.5%
|
$469,861
$49.07 P/Share
|
|
Feb 23
2022
|
Payal Sahni Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
13,884
+32.08%
|
$374,868
$27.34 P/Share
|
|
Feb 23
2022
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
57,170
-18.65%
|
$2,801,330
$49.07 P/Share
|
|
Feb 23
2022
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
76,895
+31.6%
|
$2,076,165
$27.34 P/Share
|
|
Feb 23
2022
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
29,767
-8.42%
|
$1,369,282
$46.87 P/Share
|
|
Jan 31
2022
|
Lidia Fonseca Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,680
-16.14%
|
$347,360
$52.69 P/Share
|